Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours

Pathology

Volumn 46, Issue 2, 2014, Pages 105-112

  Antonescu, Cristina R ^a   Dal Cin, Paola ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

EWSR1; FUS; HMGA2; NCOA2; Promiscuous Fusion genes; Sarcoma; Translocations

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; PATHOLOGY; RECURRENT DISEASE; SOFT TISSUE TUMOR;

GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RECURRENCE; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 84896763748     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000049     Document Type: Article

References (73)

1. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994; 372: 143-9.
2. Rabbitts TH. Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation-why are these functions targeted? J Pathol 1999; 187: 39-42.
3. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002; 110: 669-72.
4. Knezevich SR, McFadden DE, Tao W, Lim J.F., Sorensen PH A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998; 18: 184-7.
5. O'Sullivan M.J., Kyriakos M, Zhu X., et al Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod Pathol 2000; 13: 1336-46.
6. Stenman G. Fusion oncogenes and tumor type specificity-insights from salivary gland tumors. Semin Cancer Biol 2005; 15: 224-35.
7. Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007; 7: 899-910.
8. Kazmierczak B, Dal Cin P, Wanschura S, et al HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 1998; 23: 279-85.
9. Odero MD, Grand FH, Iqbal S, et al Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 2005; 19: 245-52.
10. Asp J, Persson F, Kost-Alimova M, Stenman G. CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas. Genes Chromosomes Cancer 2006; 45: 820-8.
11. Deen M, Ebrahim S, Schloff D., Mohamed AN A novel PLAG1-RAD51L1 gene fusion resulting from a t(8;14)(q12;q24) in a case of lipoblastoma. Cancer Genet 2013; 206: 233-7.
12. Antonescu CR, Zhang L, Shao S.Y., et al Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation. Genes Chromosomes Cancer 2013; 52: 675-82.
13. Oliveira AM, Perez-Atayde AR, Inwards C.Y., et al USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 2004; 165: 1773-80.
14. Erickson-Johnson M.R., Chou MM, Evers B.R., et al Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest 2011; 91: 1427-33.
15. Oliveira AM, Chou MM USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 2013.
16. Delattre O, Zucman J, Plougastel B., et al Gene fusion with an ETS DNAbinding domain caused by chromosome translocation in human tumours. Nature 1992; 359: 162-5.
17. Antonescu CR, Katabi N, Zhang L., et al EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 2011; 50: 559-70.
18. Bilodeau EA, Weinreb I, Antonescu C.R., et al Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinomas. Am J Surg Pathol 2013; 37: 1001-5.
19. Jo VY, Antonescu CR, Zhang L, Dal Cin P, Hornick JL, Fletcher CD Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases. Am J Surg Pathol 2013; 37: 710-8.
20. Panagopoulos I, Thorsen J, Gorunova L., et al RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22) (q32;q12). Genes Chromosomes Cancer 2013; 52: 733-40.
21. Delattre O, Zucman J, Melot T., et al The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331: 294-9.
22. Ginsberg JP, de Alava E, Ladanyi M, et al EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. J Clin Oncol 1999; 17: 1809-14.
23. May WA, Gishizky ML, Lessnick S.L., et al Ewing sarcoma 11; 22 translocation produces a chimeric transcription factor that requires the DNAbinding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 1993; 90: 5752-6.
24. Romeo S, Dei Tos AP. Soft tissue tumors associated with EWSR1 translocation. Virchows Arch 2010; 456: 219-34.
25. Sankar S, Lessnick SL Promiscuous partnerships in Ewing's sarcoma. Cancer Genet 2011; 204: 351-65.
26. Antonescu C. Round cell sarcomas beyond Ewing. Histopathology 2014. in press.
27. Mastrangelo T, Modena P, Tornielli S., et al A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 2000; 19: 3799-804.
28. Wang L, Bhargava R, Zheng T., et al Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 2007; 9: 498-509.
29. Szuhai K, Ijszenga M, de Jong D, Karseladze A, Tanke H.J., Hogendoorn PC The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res 2009; 15: 2259-68.
30. Sumegi J, Nishio J, Nelson M., Frayer RW, Perry D, Bridge JA A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol 2011; 24: 333-42.
31. Riggi N, Cironi L, Suva M.L., Stamenkovic I. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 2007; 213: 4-20.
32. Arvand A, Denny CT Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 2001; 20: 5747-54.
33. Sjogren H, Wedell B, Meis-Kindblom JM, Kindblom L.G., Stenman G. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21). Cancer Res 2000; 60: 6832-5.
34. Hisaoka M, Ishida T, Imamura T., Hashimoto H. TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 2004; 40: 325-8.
35. Antonescu CR, Nafa K, Segal N.H., Dal Cin P, Ladanyi M. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma-association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 2006; 12: 5356-62.
36. Antonescu CR, Dal Cin P, Nafa K, et al EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 2007; 46: 1051-60.
37. Thway K, Nicholson AG, Lawson K, et al Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity. Am J Surg Pathol 2011; 35: 1722-32.
38. Shah AA, LeGallo RD, van Zante A, et al EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma. Am J Surg Pathol 2013; 37: 571-8.
39. Antonescu CR, Zhang L, Chang N.E., et al EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer 2010; 49: 1114-24.
40. Shing DC, McMullan DJ, Roberts P, et al FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003; 63: 4568-76.
41. Ng TL, O'Sullivan MJ, Pallen CJ, et al Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007; 9: 459-63.
42. Guillou L, Benhattar J, Gengler C., et al Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol 2007; 31: 1387-402.
43. Lau PP, Lui PC, Lau G.T., Yau DT, Cheung ET, Chan JK EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol 2013; 37: 734-8.
44. Doyle LA, Hornick JL EWSR1 rearrangements in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol 2013; 37: 1630-1.
45. Hallor KH, Micci F, Meis-Kindblom JM, et al Fusion genes in angiomatoid fibrous histiocytoma. Cancer Lett 2007; 251: 158-63.
46. Ladanyi M, Lui MY, Antonescu C.R., et al The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001; 20: 48-57.
47. Argani P, Aulmann S, Illei P.B., et al A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 2010; 34: 1395-406.
48. Chang IW, Huang HY, Sung MT Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Am J Surg Pathol 2009; 33: 1894-901.
49. Ross H, Argani P. Xp11 translocation renal cell carcinoma. Pathology 2010; 42: 369-73.
50. Antonescu CR, Le Loarer F, Mosquera JM, et al Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 2013; 52: 775-84.
51. Sumegi J, Streblow R, Frayer R.W., et al Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 2010; 49: 224-36.
52. Mosquera JM, Sboner A, Zhang L., et al Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer 2013; 52: 538-50.
53. Wang L, Motoi T, Khanin R., et al Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 2012; 51: 127-39.
54. Jin Y, Moller E, Nord K.H., et al Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer 2012; 51: 510-20.
55. Arbajian E, Magnusson L, Mertens F., Domanski HA, Vult von Steyern F, Nord KH. A novel GTF2I/NCOA2 fusion gene emphasizes the role of NCOA2 in soft tissue angiofibroma development. Genes Chromosomes Cancer 2013; 52: 330-1.
56. Liang J, Prouty L, Williams B.J., Dayton MA, Blanchard KL Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 1998; 92: 2118-22.
57. Strehl S, Nebral K, Konig M., et al ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Clin Cancer Res 2008; 14: 977-83.
58. Micci F, Panagopoulos I, Bjerkehagen B., Heim S. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 2006; 66: 107-12.
59. Panagopoulos I, Micci F, Thorsen J., et al Novel fusion of MYST/Esa1associated factor 6 and PHF1 in endometrial stromal sarcoma. PLoS One 2012; 7: e39354.
60. D'Angelo E., Ali RH, Espinosa I, et al Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement. Am J Surg Pathol 2013; 37: 514-21.
61. Gebre-Medhin S., Nord KH, Moller E, et al Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. Am J Pathol 2012; 181: 1069-77.
62. Graham RP, Weiss SW, Sukov W.R., et al PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: a fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant. Am J Surg Pathol 2013; 37: 1751-5.
63. Endo M, Kohashi K, Yamamoto H., et al Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene. Hum Pathol 2013; 44: 2603-8.
64. Pierron G, Tirode F, Lucchesi C., et al A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 2012; 44: 461-6.
65. Panagopoulos I, Thorsen J, Gorunova L., et al Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X; 22-translocation. Genes Chromosomes Cancer 2013; 52: 610-8.
66. Yamamoto Y, Tsuzuki S, Tsuzuki M., Handa K, Inaguma Y, Emi N. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood 2010; 116: 4274-83.
67. Marino-Enriquez A., Dal Cin P. ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages. Cancer Genet 2013; Sep 30: (Epub ahead of print).
68. Debiec-Rychter M., Marynen P, Hagemeijer A., Pauwels P. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003; 38: 187-90.
69. Panagopoulos I, Nilsson T, Domanski H.A., et al Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int J Cancer 2006; 118: 1181-6.
70. Marino-Enriquez A., Wang WL, Roy A, et al Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 2011; 35: 135-44.
71. Tognon C, Knezevich SR, Huntsman D, et al Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002; 2: 367-76.
72. Skalova A, Vanecek T, Sima R., et al Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010; 34: 599-608.
73. Eguchi M, Eguchi-Ishimae M, Tojo A., et al Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15) (p13;q25). Blood 1999; 93: 1355-63.